BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, June 23, 2026
Breaking News: Ongoing coverage of the Ebola outbreak
Breaking News: Ongoing coverage of the Ebola outbreak
Breaking News: Ongoing coverage of the Ebola outbreak
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
alpha2A-Adrenoceptor gene polymorphism and overexpression linked to type 2 diabetes
March 4, 2010
Shionogi and QuatRx to market and develop ospemifene
March 3, 2010
Watson Pharmaceuticals licenses Population Council's novel contraceptive ring
March 2, 2010
FDA accepts for filing VIVUS' Qnexa NDA for obesity
March 2, 2010
Prosidion claims new glucose-dependent insulinotropic receptor agonists
March 2, 2010
FDA grants marketing approval for Shire's VPRIV for type 1 GD
March 1, 2010
Corcept Therapeutics begins phase I CORT-108297 trial
March 1, 2010
Once-weekly exenatide NDA review for type 2 diabetes extended by FDA
Feb. 26, 2010
GSK criticizes Senate Committee on Finance's report on Avandia
Feb. 25, 2010
Shire receives FDA fast track designation for Replagal
Feb. 25, 2010
Previous
1
2
…
710
711
712
713
714
715
716
717
718
…
1797
1798
Next
RSS